Issuance of Common Stock for Litigation Settlement

No definition available.

Name:	gale_IssuanceofCommonStockforLitigationSettlement
Namespace Prefix:	gale_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of judgment or settlement awarded to (against) the entity in respect of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of cash paid for the settlement of litigation or for other legal issues during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585

+ Details

Name:	us-gaap_PaymentsForLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash inflow from the amounts received by the insured under the terms of an insurance contract settlement. This element pertains only to insurance proceeds related to operating activities. It excludes insurance settlements classified as investing cash flows, for example, insurance settlements related to fixed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 16
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3337-108585

+ Details

Name:	us-gaap_ProceedsFromInsuranceSettlementOperatingActivities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_LitigationCaseAxis=gale_GalenaBiopharmaInc.SecuritiesLitigationCivilActionNo.314cv00367SIMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=gale_GalenaBiopharmaInc.DerivativeLitigationCivilActionNo.314cv00382SIMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=gale_ShareholdersSecuritiesLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Legal Proceedings, Commitments and Contingencies (Schedule of Litigation Settlements) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended		9 Months Ended
	Jun. 30, 2016	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016
Loss Contingencies [Line Items]
Total settlements		$ (1,800)	$ 0	$ (1,800)	$ 0	$ 26,800
Payable by the insurance carriers				21,700
Galena Biopharma, Inc. Securities Litigation, Civil Action No. 3:14-cv-00367-SI [Member]
Loss Contingencies [Line Items]
Total settlements				(20,000)
Galena Biopharma, Inc. Derivative Litigation, Civil Action No. 3:14-cv-00382-SI [Member]
Loss Contingencies [Line Items]
Total settlements				(5,000)
Shareholders Securities Litigation [Member]
Loss Contingencies [Line Items]
Total settlements				$ (1,800)
Scenario, Forecast [Member]
Loss Contingencies [Line Items]
Payable by the company in cash (paid in July 2016)	$ 2,450
Payable by the company in common stock (paid in July 2016)	$ 2,650